$278.20
$-3.76 (-1.33%)
End-of-day quote: 05/29/2024
ASX:CSL
CSL Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr911.50 | kr696.07 | 0.00% | 14 | kr4.04T |
| JNJ | Johnson & Johnson | NYSE | Outperform | $144.44 | $174.55 | 0.00% | 3 | $347.62B |
| MRK | Merck | NYSE | Outperform | $125.90 | $130.51 | 0.00% | 11 | $318.88B |
| AZN | AstraZeneca PLC | LSE | Outperform | £119.30 | £165.99 | 0.00% | 16 | £184.94B |
| NOVN | Novartis | SWX | Hold | CHF90.51 | CHF105.00 | 0.00% | 9 | CHF184.68B |
| ABT | Abbott Laboratories | NYSE | Outperform | $100.73 | $118.92 | 0.00% | 7 | $175.23B |
| PFE | Pfizer | NYSE | Outperform | $27.82 | $32.87 | 0.00% | 6 | $157.64B |
| SAN | Sanofi | ENXTPA | Outperform | 87.71€ | 102.80€ | 0.00% | 9 | 109.65€B |
| VRTX | Vertex Pharmaceuticals Inc | NASDAQ | Outperform | $441.13 | $457.59 | 0.00% | 11 | $113.84B |
| GSK | GSK | LSE | Outperform | £17.47 | £17.30 | 0.00% | 12 | £71.22B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $63.50 | $87.82 | 0.00% | 14 | $79.11B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.11k | ¥4.74k | 0.00% | 0 | ¥6.45T |
| BIIB | Biogen | NasdaqGS | Outperform | $214.41 | $299.62 | 0.00% | 13 | $31.22B |
| BAYN | Bayer | XTRA | Hold | 26.93€ | 45.15€ | 0.00% | 4 | 26.45€B |
| UCB | UCB | ENXTBR | Outperform | 127.20€ | 102.66€ | 0.00% | 7 | 24.14€B |
| 4503 | Astellas Pharma | TSE | Outperform | ¥1.54k | ¥2.64k | 0.00% | 0 | ¥2.75T |
| BAX | Baxter International Inc | NYSE | Hold | $33.19 | $44.86 | 0.00% | 5 | $16.91B |
| SOBI | Swedish Orphan Biovitrum AB (p... | OM | Outperform | kr272.80 | kr293.00 | 0.00% | 6 | kr96.39B |
| 600161 | Beijing Tiantan Biological Pro... | SHSE | Outperform | ¥28.21 | ¥31.28 | 0.00% | 1 | ¥50.09B |
| 002252 | Shanghai RAAS Blood Products | SZSE | Outperform | ¥7.16 | ¥9.08 | 0.00% | 0 | ¥49.67B |
| GRF | Grifols | BME | Outperform | 9.01€ | 18.48€ | 0.00% | 3 | 5.85€B |
| 002007 | Hualan Biological Engineering | SZSE | Outperform | ¥18.36 | ¥25.89 | 0.00% | 0 | ¥36.17B |
| ITRI | Itron | NasdaqGS | Outperform | $108.25 | $77.33 | 0.00% | 0 | $4.98B |
| BIOCON | Biocon | NSEI | Hold | Rp323.60 | Rp270.86 | 0.00% | 14 | Rp365.06B |
| PFIZER | Pfizer | NSEI | Outperform | Rp4.62k | Rp4.53k | 0.00% | 3 | Rp204.63B |
| ADMA | ADMA Biologics | NasdaqGM | Buy | $9.40 | $6.00 | 0.00% | 0 | $2.04B |
| BIO3 | Biotest | XTRA | Hold | 27.60€ | 37.00€ | 0.00% | 0 | 1.38€B |
| BCRX | BioCryst Pharmaceuticals | NasdaqGS | Outperform | $6.15 | $14.09 | 0.00% | 2 | $1.09B |
| PHARM | Pharming Group N.V. | ENXTAM | Buy | 0.81€ | 1.85€ | 0.00% | 2 | 591.95€M |
| NVAX | Novavax | NasdaqGS | Outperform | $15.11 | $23.25 | 0.00% | 4 | $623.13M |
| 4105 | TTY Biopharm Company | TPEX | Hold | NT$77.00 | NT$86.00 | 0.00% | 0 | NT$19.22B |
| KALV | KalVista Pharmaceuticals | NasdaqGM | Buy | $11.15 | $20.80 | 0.00% | 0 | $478.84M |
| 4142 | Adimmune | TWSE | - | NT$31.05 | NT$55.00 | 0.00% | 0 | NT$14.08B |
| KENDR | Kendrion N.V. | ENXTAM | Outperform | 13.82€ | 15.17€ | 0.00% | 2 | 202.56€M |
| ABEO | Abeona Therapeutics | NasdaqCM | Buy | $4.06 | $21.25 | 0.00% | 2 | $114.89M |
| 6833 | Sinco Pharmaceuticals Holdings | SEHK | - | HK$0.23 | HK$0.46 | 0.00% | 0 | HK$528.55M |
| LUPA3 | Lupatech | BOVESPA | - | R$1.60 | R$1.90k | 0.00% | 0 | R$67.78M |
